Guaza C - Search Results

1

Endocannabinoids drive the acquisition of an alternative phenotype in microglia.

Mecha M, Feliú A, Carrillo-Salinas FJ, Rueda-Zubiaurre A, Ortega-Gutiérrez S, de Sola RG, Guaza C. Mecha M, et al. Among authors: guaza c. Brain Behav Immun. 2015 Oct;49:233-45. doi: 10.1016/j.bbi.2015.06.002. Epub 2015 Jun 15. Brain Behav Immun. 2015. PMID: 26086345

2

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

Ortega-Gutiérrez S, Molina-Holgado E, Guaza C. Ortega-Gutiérrez S, et al. Among authors: guaza c. Glia. 2005 Nov 1;52(2):163-8. doi: 10.1002/glia.20229. Glia. 2005. PMID: 15920730

3

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.

Ortega-Gutiérrez S, Molina-Holgado E, Arévalo-Martín A, Correa F, Viso A, López-Rodríguez ML, Di Marzo V, Guaza C. Ortega-Gutiérrez S, et al. Among authors: guaza c. FASEB J. 2005 Aug;19(10):1338-40. doi: 10.1096/fj.04-2464fje. Epub 2005 Jun 7. FASEB J. 2005. PMID: 15941768

4

The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.

Mestre L, Correa F, Docagne F, Clemente D, Guaza C. Mestre L, et al. Among authors: guaza c. Biochem Pharmacol. 2006 Sep 28;72(7):869-80. doi: 10.1016/j.bcp.2006.06.037. Epub 2006 Aug 17. Biochem Pharmacol. 2006. PMID: 16914119

5

[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].

Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C. Mestre L, et al. Among authors: guaza c. Rev Neurol. 2006 Nov 1-15;43(9):541-8. Rev Neurol. 2006. PMID: 17072810 Free article. Review. Spanish.

6

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

Correa F, Docagne F, Clemente D, Mestre L, Becker C, Guaza C. Correa F, et al. Among authors: guaza c. Biochem J. 2008 Feb 1;409(3):761-70. doi: 10.1042/BJ20071329. Biochem J. 2008. PMID: 17961121 Free article.

7

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.

Correa F, Docagne F, Mestre L, Clemente D, Hernangómez M, Loría F, Guaza C. Correa F, et al. Among authors: guaza c. Biochem Pharmacol. 2009 Jan 1;77(1):86-100. doi: 10.1016/j.bcp.2008.09.014. Epub 2008 Sep 20. Biochem Pharmacol. 2009. PMID: 18848818

8

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

Correa F, Hernangómez M, Mestre L, Loría F, Spagnolo A, Docagne F, Di Marzo V, Guaza C. Correa F, et al. Among authors: guaza c. Glia. 2010 Jan 15;58(2):135-47. doi: 10.1002/glia.20907. Glia. 2010. PMID: 19565660

9

The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.

Correa FG, Mestre L, Docagne F, Borrell J, Guaza C. Correa FG, et al. Among authors: guaza c. Vitam Horm. 2009;81:207-30. doi: 10.1016/S0083-6729(09)81009-1. Vitam Horm. 2009. PMID: 19647114 Review.

10

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.

Loría F, Petrosino S, Hernangómez M, Mestre L, Spagnolo A, Correa F, Di Marzo V, Docagne F, Guaza C. Loría F, et al. Among authors: guaza c. Neurobiol Dis. 2010 Jan;37(1):166-76. doi: 10.1016/j.nbd.2009.09.020. Epub 2009 Oct 6. Neurobiol Dis. 2010. PMID: 19815071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters